114027
论文已发表
注册即可获取德孚的最新动态
IF 收录期刊
- 3.4 Breast Cancer (Dove Med Press)
- 3.2 Clin Epidemiol
- 2.6 Cancer Manag Res
- 2.9 Infect Drug Resist
- 3.7 Clin Interv Aging
- 5.1 Drug Des Dev Ther
- 3.1 Int J Chronic Obstr
- 6.6 Int J Nanomed
- 2.6 Int J Women's Health
- 2.9 Neuropsych Dis Treat
- 2.8 OncoTargets Ther
- 2.0 Patient Prefer Adher
- 2.2 Ther Clin Risk Manag
- 2.5 J Pain Res
- 3.0 Diabet Metab Synd Ob
- 3.2 Psychol Res Behav Ma
- 3.4 Nat Sci Sleep
- 1.8 Pharmgenomics Pers Med
- 2.0 Risk Manag Healthc Policy
- 4.1 J Inflamm Res
- 2.0 Int J Gen Med
- 3.4 J Hepatocell Carcinoma
- 3.0 J Asthma Allergy
- 2.2 Clin Cosmet Investig Dermatol
- 2.4 J Multidiscip Healthc
已发表论文
槲皮素相关铁死亡基因特征在肝细胞癌中的预后意义及机制见解
Authors Yao W, Li H, Zhang Y, Xia X, Wang H, Zhang Z, Shi D
Received 14 August 2025
Accepted for publication 6 December 2025
Published 23 December 2025 Volume 2025:12 Pages 2919—2937
DOI https://doi.org/10.2147/JHC.S560755
Checked for plagiarism Yes
Review by Single anonymous peer review
Peer reviewer comments 2
Editor who approved publication: Dr David Gerber
Weifeng Yao,1,* Hui Li,2,* Yongle Zhang,1 Xufen Xia,1 Hai Wang,1 Zhen Zhang,1 Danfang Shi1
1Department of Clinical Laboratory, Tongde Hospital of Zhejiang Province, Hangzhou, People’s Republic of China; 2Key Laboratory of Neuroregeneration of Jiangsu and Ministry of Education, Co-Innovation Center of Neuroregeneration, Medical School of Nantong University, Nantong University, Nantong, People’s Republic of China
*These authors contributed equally to this work
Correspondence: Danfang Shi, Department of Clinical Laboratory, Tongde Hospital of Zhejiang Province, Hangzhou, People’s Republic of China, Email 1830927743@qq.com
Purpose: This study aims to elucidate the anti-tumor properties of rutin and its specific molecular mechanisms for inhibiting hepatocellular carcinoma (HCC) through the ferroptosis.
Methods: The effects of rutin on HuH-7 cell proliferation, migration, invasion, and cell cycle progression were evaluated through in vitro experiments. By integrating bioinformatics analysis and network pharmacology, potential ferroptosis targets influenced by rutin in HCC were identified from the TCGA-LIHC database. A prognosis-related risk-scoring model was constructed and validated in the GEO14520 cohort and ICGC-LIRI-JP. Samples were categorized into high-risk and low-risk groups based on their scores. Enriched pathways within these different risk groups were explored using Gene Set Enrichment Analysis (GSEA) and Gene Set Variation Analysis (GSVA). Additionally, key targets of rutin-related ferroptosis in HCC cells were investigated through single-cell analysis and molecular docking studies.
Results: Rutin inhibited the proliferation, invasion, migration, and cell cycle progression of HCC cells in a dose-dependent manner. We constructed a risk model comprising five ferroptosis-related targets of rutin (FRTs-R): ACACA, AKR1C3, ALDH2, AR, and CDK1. This prognostic model was validated in the GEO14520 and ICGC datasets, revealing that the low-risk group had a better prognosis than the high-risk group. Furthermore, lipid metabolism pathway activity was up-regulated in the low-risk group. Single-cell analysis indicated specific expression of AKR1C3 in HCC cells, while molecular docking analysis showed that, among the five potential targets, AKR1C3 demonstrated the most stable binding affinity to rutin.
Conclusion: Our findings suggest that rutin may modulate ferroptosis in HCC, with rutin associated ferroptosis genes implicated in disease biology; moreover, the proposed risk scoring model shows promising prognostic utility in HCC.
Keywords: hepatocellular carcinoma, rutin, ferroptosis, bioinformatics, in vitro experiment
1Department of Clinical Laboratory, Tongde Hospital of Zhejiang Province, Hangzhou, People’s Republic of China; 2Key Laboratory of Neuroregeneration of Jiangsu and Ministry of Education, Co-Innovation Center of Neuroregeneration, Medical School of Nantong University, Nantong University, Nantong, People’s Republic of China
*These authors contributed equally to this work
Correspondence: Danfang Shi, Department of Clinical Laboratory, Tongde Hospital of Zhejiang Province, Hangzhou, People’s Republic of China, Email 1830927743@qq.com
Purpose: This study aims to elucidate the anti-tumor properties of rutin and its specific molecular mechanisms for inhibiting hepatocellular carcinoma (HCC) through the ferroptosis.
Methods: The effects of rutin on HuH-7 cell proliferation, migration, invasion, and cell cycle progression were evaluated through in vitro experiments. By integrating bioinformatics analysis and network pharmacology, potential ferroptosis targets influenced by rutin in HCC were identified from the TCGA-LIHC database. A prognosis-related risk-scoring model was constructed and validated in the GEO14520 cohort and ICGC-LIRI-JP. Samples were categorized into high-risk and low-risk groups based on their scores. Enriched pathways within these different risk groups were explored using Gene Set Enrichment Analysis (GSEA) and Gene Set Variation Analysis (GSVA). Additionally, key targets of rutin-related ferroptosis in HCC cells were investigated through single-cell analysis and molecular docking studies.
Results: Rutin inhibited the proliferation, invasion, migration, and cell cycle progression of HCC cells in a dose-dependent manner. We constructed a risk model comprising five ferroptosis-related targets of rutin (FRTs-R): ACACA, AKR1C3, ALDH2, AR, and CDK1. This prognostic model was validated in the GEO14520 and ICGC datasets, revealing that the low-risk group had a better prognosis than the high-risk group. Furthermore, lipid metabolism pathway activity was up-regulated in the low-risk group. Single-cell analysis indicated specific expression of AKR1C3 in HCC cells, while molecular docking analysis showed that, among the five potential targets, AKR1C3 demonstrated the most stable binding affinity to rutin.
Conclusion: Our findings suggest that rutin may modulate ferroptosis in HCC, with rutin associated ferroptosis genes implicated in disease biology; moreover, the proposed risk scoring model shows promising prognostic utility in HCC.
Keywords: hepatocellular carcinoma, rutin, ferroptosis, bioinformatics, in vitro experiment